Gamma-aminobutyric acid (GABA) is involved in the proliferation, differentiation, and migration of several cell types including cancer cells. Whether GABA may be involved with acute lymphoblastic leukemia (ALL) is unclear. Therefore, the goal of this report was to examine if GABAergic signaling expression is altered in bone marrow lymphocytes of ALL children. RT-PCR and western blot analysis were used to examine the expression of the GABA synthetizing enzyme glutamic acid decarboxylase (GAD) isoforms (GAD65 and GAD67), and type-A GABA receptor (GABA A R) subunits [α(1-6), β(1-3), γ(1-3), δ, ε, θ, π, and ρ(1-3)] in bone marrow lymphocytes of 19 ALL children before chemotherapy. The data obtained were compared with those in 13 age-matched non-ALL children. Immunofluorescent staining was used to examine the cellular localization of GAD. We found that GAD and GABA A R subunits were expressed in bone marrow lymphocytes of ALL children. Moreover, RT-PCR and western blot showed that GAD and several GABA A R subunits were significantly increased in ALL children as compared with the data of non-ALL children. Our present study reveals up-regulation of GABAergic signaling events in bone marrow lymphocytes in ALL children. However, the role of this signaling system in lymphocyte proliferation and invasion as related to the progression of ALL requires further investigation.
Introduction
Acute leukemia, of which approximately 80% is lymphoblastic, comprises 31% of all cancers in children (14) . Childhood acute lymphoblastic leukemia (ALL), characterized by excessive proliferation and invasion of lymphoblasts (leukemic cells), is one of leading causes of death in children (22) , although the cure rate in early diagnosed ALL has been reported to be at 85% in developed countries (3, 15) . The identification of biological features that influence cell survival, proliferation and differentiation in ALL, as well as effective targets for treatment, and the risk of failure in treatment represent topics of current interest for investigation (19) .
GABA is a major inhibitory neurotransmitter in the adult brain (16) , which is synthesized from glutamic acid by two isoforms of glutamic acid decarboxylase (GAD65 and GAD67, with 65 and 67 kD molecular weight, respectively). GABA induces a rapid inhibitory effect in neurons by activation of the type-A GABA receptors (GABA A Rs), which are pentameric ligand-gated Cl -ion channels, that results in Cl -influx and membrane hyperpolarization (16) . In mammals, 19 GABA A R subunits have been cloned: α1-6, β1-3, γ1-3, δ, ε, π, θ, and ρ1-3 (26) . GABA also exerts trophic actions in the developing brain by regulating neuronal cell proliferation and maturation (13, 23) . In addition, some non-neuronal cells express a GABA A R-mediated autocrine signaling mechanism. For instance, it has been reported that activation of GABA A R-mediated autocrine signaling in embryonic stem cells controls cell proliferation (2) .
It is interesting to note that lymphocytes express both GAD and functional GABA A Rs (11), indicating that lymphocytes are endowed with an auto-or paracrine GABAergic signaling mechanism. The physiological and pathophysiological relevance of GABA-GABA A Rs signaling in lymphocytes remains obscure and, therefore, under active investigation. It has been shown that GABA inhibits proinflammatory CD4 + T cell response (11) and modulates CD8 + T cells cytotoxicity in vitro (4) . Moreover, GABA decreases T-cell autoimmunity and the development of inflammatory responses in a mouse model of type 1 diabetes (25) . Taken together, the above reports suggest that GABAergic signaling may mediate immunoinhibition. Whether GABAergic signaling affects lymphocyte proliferation is controversial. Bjurstöm and colleagues reported that GABA halted proliferation of activated lymphocytes (7), whereas a study by Bhat and colleagues showed that GABAergic agents had no direct effect on T-cell proliferation (5) . In addition, it is unclear whether GABAergic signaling events exist in lymphoblasts and whether it plays a role in the pathogenesis of ALL.
Considering the important role of the GABAergic signaling system in regulating neuronal and nonneuronal cell proliferation, we hypothesized that GABAergic signaling events may exist in lymphocytes, and may also play a role in regulating leukemic cell proliferation in ALL children. In an attempt to address these issues, the present study was performed to determine whether GABAergic signaling was altered in lymphocytes in ALL children. A sample size of 19 ALL children and 13 non-ALL children was included in this report as calculated assuming a power of greater than 80 and 5 percent levels of significance and based on our pilot experiments. These 32 children were selected randomly from 83 outpatients and inpatients aged 3 to 6 years old who were subjected to bone marrow aspiration (BMA) for the diagnosis of ALL in the Department of Pediatric Hematology and Oncology of the Provincial Hospital Affiliated with Shandong University. Fifty-two of these 83 children agreed to participate in this study with the adequate understanding and written consent of their supervisors. As based upon the results obtained from the bone marrow morphology test, acute leukemia immunophenotyping, and chromosome and fusion gene test, 21 of these 52 children were newly diagnosed with ALL (19 were diagnosed with acute B-lymphoblastic leukemia and were enrolled in this study, while the remaining 2 were diagnosed with acute T-lymphoblastic leukemia and were excluded from the study because of sample size limitation). The remaining 31 children were diagnosed as non-ALL, 13 of whom with normal bone marrow were used as the reference control group, and the remaining 18 with abnormal bone marrow (11 of them were diagnosed with aplastic anemia, 7 of them were diagnosed with acute myeloid leukemia) were excluded from the study. The 19 ALL children, who had not been subjected to any chemotherapy before BMA, consisted of 11 males and 8 females while the 13 non-ALL children had 8 males and 5 females.
Materials and Methods

Subjects
Bone Marrow Aspiration (BMA) and Separation of Bone Marrow Lymphocytes
Bone marrow was collected from the sternum or the anterior tibia by means of BMA, using EDTA as anticoagulant. Lymphocytes were separated from the bone marrow using a separating solution (mainly composed of dextranum and Cardiografin) according to the manufacturer's instructions (Tian Jin HAO YANG Biological Manufacture CO., LTD, Tian Jin, PRC). Briefly, the bone marrow was diluted by an equal volume of saline, loaded onto the separating solution, and centrifuged for 20 min at 2,000 rpm. Lymphocytes were washed twice with saline, resuspended in saline, and then centrifuged for 20 min at 2,000 rpm. The supernatant was then collected and stored at -80°C for further studies.
Western Blot Analysis
Purified lymphocytes were lysed in RIPA buffer containing 50 mM Tris-HCl, 10 mM EDTA, 1% Triton X-100, 2 mM PMSF and 10 mg/ml each of aprotinin and leupeptin. The protein concentration was determined by a Bradford assay, using bovine serum albumin as a standard (10) . The supernatant containing 100 μg total protein was diluted in 2x sample buffer, loaded onto 10% SDS-PAGE, and transferred to nitrocellulose membranes. After being blocked with blocking buffer (5% non-fat dry milk in Tween-Tris-buffered saline), the membranes were treated with antibodies specific for GAD65/67 (Sigma, St. Louis, MO, USA), GABA A R β2-3 (Millopore, Billerica, MA, USA), or GABA A R α1 subunits (Millopore) as primary antibodies and horseradish-labeled goat anti-rabbit IgG antibody (Sigma) as the secondary antibody. Specific immunoreactive bands were detected using an ECL system (Amersham Biosciences, Buckinghamshire, UK). Densitometric analysis was performed using Scion Image for Windows supplied by the Scion Corporation, USA. For immunoblotting assays of GAD65/67 and GABA A R subunits, a rat cerebral cortex was used as the positive control.
Immunofluorescent Staining
Bone marrow slides were fixed using 4% paraformaldehyde. After fixation for 20 min, slides were permeabilized with 0.1% Triton X-100, blocked with 10% donkey serum for 60 min, and then incubated overnight at 4°C with rabbit anti-GAD65/67 (Sigma). Primary antibodies were omitted in negative controls to ensure stain specificity. Slides were subsequently incubated with a Cy3-conjugated secondary antibody (Invitrogen, NY, USA) for 30 min at room temperature. Confocal images were visualized using a CarlZeiss laser confocal fluorescence microscope (model 780) and Zeiss LSM program. The fluorescence intensity for a specific protein stain was set below the threshold for the negative control and analyzed using the Image J software.
RT-PCR
Purified lymphocytes were homogenized in Trizol for total RNA extraction. RNA reverse transcription was performed using the high capacity cDNA reverse transcription kit (Applied Biosystems, Carlsbad, CA, USA). The primer pairs used are shown in Table 1 .
Statistical Analysis
Data are expressed as the mean ± standard errors and were compared by means of unpaired Student's t-test. P < 0.05 was considered as being statistically significant. All statistical analyses were performed using the SPSS software (Chicago, USA)
Results
Expression of GAD and GABA A R Subunits in Bone Marrow Lymphocytes of ALL Children
Using an antibody that recognizes both the GAD65 and the GAD67 isoforms (GAD65/67), immunofluorescent staining of GAD65/67 in bone marrow smears of ALL children was initially performed. Confocal microscopy of the stained bone marrow smears showed that GAD65/67 was expressed in the cytoplasm of all lymphocytes (Fig. 1A, left panel, arrow) . In accordance with the immunostaining result, western blot assays detected the expression of GAD65/67, GABA A R α1 and GABA A R β2/3 subunits, which are thought to be contained in most GABA A Rs (6), in the separated bone marrow lymphocytes of 19 ALL children. Of note, the expression profiles of GAD65/67 and beta 2/3 subunit in bone marrow lymphocytes were different from those in rat cortices that were used as positive controls in our immunoblot assays. For GAD, the results showed that only GAD65 was expressed in lymphocytes, and for the β2/3 sub-unit, only a 57 kD band was detected. Taken together, the immunostaining and immunoblot results revealed that bone marrow lymphocytes of ALL children possessed GABA production mechanisms and the presence of GABA A Rs, thus forming the potential for complete GABAergic signaling events.
Up-Regulation of GABAergic Signaling in Bone Marrow Lymphocytes of ALL Children
RT-PCR analysis of the separated lymphocytes was next performed to investigate whether the expression levels of GABAergic signaling events in ALL children differ from those of non-ALL children. In contrast to the immunoblot results, no GAD65 mRNA expression was detected in either ALL or non-ALL children. Interestingly, GAD67 mRNA expression was higher in ALL compared to non-ALL children (473.2 ± 45.1% of non-ALLs, n = 19, P < 0.05). Similarly, mRNA expression levels of the GABA A R subunits α1, α5, β2, β3, γ2, ρ2, ε, and π in lymphocytes were all significantly increased in ALL versus non-ALL children (214.9 ± 23.2%, 293.7 ± 43.6%, 219.7 ± 17.9%, 477.0 ± 44.2%, 400.1 ± 36.1%, 497.5 ± 32.7%, 320.7 ± 28.7%, and 179.4 ± 23.9% of non-ALLs, respectively, n = 19, P < 0.05, Figs. 2A and 2B ). In agreement with our RT-PCR findings, western blot results revealed that GABA A R β2/3 subunit protein expression in lymphocytes was significantly increased in ALL children compared with that of non-ALL children (297.4 ± 28.2% of non-ALLs, n = 19, P < 0.05, Figs. 2C and 2D ). Taken together, these results demonstrated that GABAergic signaling events were up-regulated in bone marrow lymphocytes of ALL children. 
Discussion
The findings of this study demonstrate potential involvement of GABAergic signaling events in bone marrow lymphocytes of ALL children. GAD expression was shown in bone marrow lymphocytes in immunostaining. Expression of GAD (GAD65 but not GAD67) and some GABA A R (α1 and β2/3) subunits was also detected in western blot analysis. In contrast, mRNA encoding GAD67, but not GAD65, was expressed in both ALL and non-ALL children. This apparent conflict in the results between mRNA and protein levels of GAD expression requires further investigation to resolve. The RT-PCR results are in agreement with that of Dionisio and colleagues, who reported only GAD67 mRNA expression in human peripheral blood lymphocytes (11) . GAD67 is believed to provide GABA to function as a signaling molecule during development, source of energy, regulator of redox potential during oxidative stress (9) , and neurotransmission in GAD65 knockout mice (27) . Our findings, together with those of Dionisio and colleagues (11) , reveal that bone marrow lymphocytes in ALL children may serve as a source of peripheral GABA. However, the concentrations as well as the mechanism of GABA release from the bone marrow of ALL children remain to be investigated.
Our RT-PCR experiments also demonstrated that mRNAs corresponding to several GABA A Rs (Fig. 2) were expressed in both bone marrow lymphocytes of ALL and non-ALL children. This result is consistent with previous studies showing that functional GABA A Rs are expressed in lymphocytes (7, 11, 25) . We also demonstrate up-regulation of GAD and several GABA A R subunits in ALL children compared to that in non-ALL controls. However, it was not possible to identify differences in the composition or function of GABA A Rs on the membranes of bone marrow lymphocytes between ALL and non-ALL children in the present experiment.
The pathophysiological significance of this upregulation of GABAergic signaling events is currently unknown. Nevertheless, findings reported here provide a foundation to speculate on some potential implications. Firstly, if the increased GABA resulting from GAD up-regulation in lymphocytes has an autoor paracrine effect on B cells, T cells, antigen-presenting cells or macrophages, which express GABA A Rs as previously reported (5), it may have a direct impact on the progression of ALL. Secondly, the increased GABA A R subunits on the membranes of bone marrow lymphocytes, together with increased concentrations of GABA derived from GAD up-regulation in the bone marrow, could possibly change the number or composition of GABA A Rs on cell membranes, thereby affecting the nature of GABA A Rs in lymphocytes, contributing to lymphoblast proliferation or invasion in ALL children. Finally, since the intracellular Cl -concentrations of lymphocytes were reported to be about 30 mM (21) , up-regulation and activation of GABAergic signaling events might depolarize lymphocytes by causing an efflux of Cl -, resulting in inhibition of the CRAC channels in lymphocytes and reduction of Ca 2+ influx (1), thus affecting Ca 2+ -dependent gene expression and epigenetic changes in lymphocytes (12) . In conclusion, the present study reveals an up-regulation of GABAergic signaling events in bone marrow lymphocytes of ALL children. Further investigations will be required to understand the role and implications of this GABA signaling events in lymphocyte proliferation and invasion under physiological and malignant conditions. Subsequently, development of strategies for using GABAergic drugs for treating ALL may be realized.
